HomeOpen Access NewsHealth & Social Care

Health & Social Care

Lessons learned from a hospital’s digital pathology journey

Pathologists play a crucial part in patient treatment, particularly in cancer care. However, the field faces challenges such as resource shortages, workflow inefficiencies, and increasing complexity. To adapt, pathology departments are embracing digital solutions to enhance diagnostics and support the transformation of healthcare.

Rare case of brain inflammation after mild COVID-19 infection

Physicians at University of California San Diego School of Medicine describe the first known case of a young, healthy adult who suffered brain inflammation after mild COVID-19 infection.

Natural ways to lower your blood pressure

Dr Deborah Lee, Dr Fox Online Pharmacy, tells us about all the way you can naturally lower your blood pressure without medical intervention.

Health innovation is key to resolving challenges faced by the NHS

Lorna Green, Director of Enterprise and Growth, describes the role of the Innovation Agency and the AHSN Network across England and how health innovation is increasingly becoming integral to resolving the long-term challenges faced by the NHS.

Moderna vaccine 93% effective six months after second dose

The Moderna vaccine appears to be 93% effective, six months after the second dose - but CEO Stéphane Bancel says "we must remain vigilant".

Fenofibrate could reduce COVID-19 infection by 70%

According to a new study, fenofibrate, a drug used to treat abnormal levels of fatty substances in the blood, could reduce COVID-19 infection by up to 70%.

NHS says 20% of people hospitalised with COVID are young

New figures from the NHS show that 20% of people hospitalised with COVID right now are young - between the ages of 18 to 34.

Pfizer-BioNTech vaccine to be offered to 16-17-year-olds

The Joint Committee on Vaccination and Immunisation (JCVI) has recommended that all 16 and 17-year-olds should receive their first dose of the Pfizer-BioNTech vaccine.

European commission approves contract for Novavax vaccine

The European Commission has approved a new contract that will allow Member States to purchase up to 100 million doses of the Novavax vaccine.

UK study finds long-term COVID effects rare in children

This UK-based study, published in The Lancet, finds that long-term COVID effects are rare in children - usually, the illness is over after six days.

Transgender youth experience “pervasive stigma” in healthcare

In a review of 91 studies across 17 countries, transgender and nonbinary youth were found to deal with "pervasive stigma and discrimination" in healthcare.

NHS Track and Trace app will ‘ping’ fewer contacts to isolate

Fewer contacts will be notified to self-isolate following updates to the NHS COVID-19 Track and Trace app.

Study finds US ‘Muslim ban’ led to decrease in healthcare access

When the controversial US 'Muslim Ban' was signed in 2017, Muslim visits to emergency departments and appointments decreased - highlighting a connection between immigration rhetoric and healthcare access.

Price of COVID vaccines to rise as they become variant-ready

France's Junior Minister for European Affairs, Clément Beaune, said that the price of COVID vaccines Pfizer and Moderna rose after being adapted for the Delta variant.

£1.1 million given for Long Covid research

A new research project, known as LISTEN, has been awarded £1.1 million of UK government funding to support people with Long Covid.

NHS say 170,000 Moderna jabs to expire in next two weeks

According to The Guardian, the NHS is concerned that 170,000 Moderna jabs will expire soon - as vaccine take-up in the 18-25 year old bracket slows down.

Long Covid: The long road to recovery

Suzanne Marshall, Clinical Governance Officer at FirstCare, discusses how the UK public sector can cope with the expected rise in long Covid.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders